NCT05507840Not yet recruiting
Photobiomodulation for Dry Age Related Macula Degeneration
Source: ClinicalTrials.gov · Last updated 12 Oct 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The study will investigate the effect of photobiomodulation treatment on the risk of developing late age related macula degeneration (AMD) in the study eye in patients with wet AMD in the fellow eye.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 121 (estimated)
- First submitted
- 30 Jun 2022
- Start date
- 1 Dec 2022
- Primary completion date
- 1 Dec 2026
- Lead sponsor
- Oslo University Hospital
- Diseases
- Macular degeneration
- NCT number
- NCT05507840
What you commit to
- Study type: Interventional
- Planned participants: 121
- From 1 Dec 2022 to the primary completion date, 1 Dec 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous/ active wet AMD in the study eye
- Change in AREDS 2 supplements (vitamins) 1 month before the study and during the study trial was allowed.
- Ongoing systemic medications that are photosensitizing (e.g. tetracyclins)
- Systemic medications during the last 6 months that can cause deposits in the macular region (hydroxychloroquine, amiodarone)
Other illness
- A history of epilepsy
- Retinal diseases apart from AMD
Other
- Geographic atrophy of the central macular region at enrolment
- Significant media opacities
- Cataracts worse than grade 2 (LOCS III classification)
- Unable to give informed consent
- Unable to cooperate with the treatment and follow-up
Who the study is looking for
- patients with dry AMD in the study eye and wet AMD in the control eye
Age in the registry: 50 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.